Tuesday, September 08, 2020 9:16:45 PM
I hope so. Opportunity to buy more shares. This is not a typical shady penny stock. Lots of meat on the bones on this one. As a physician who uses Peptides in my practice, has extensive ICU work history, and has done my due diligence on this therapy, I am as confident as I can be that this drug and stock have amazing potential. I rarely hold a penny stock long (In fact, I never do). They are penny stocks for a reason (risky and unproven). But every once in a while something happens that causes disruptive innovation. For a penny stock, this breaks the mold. Flippers do not know about or care about the science of the product. BTW, I don't blame them. Their knowledge and training is around patterned market behavior. It serves well as it eliminates emotional decision making.; a critical flaw if you are a day or swing trader. I will also share that I have knowledge in the investing world as well, as I day and swing trade myself. IMHO (strong opinion) this stock is the exception to the rule. I am a humble guy who rarely puts his neck out there in public for fear of the guillotine. In a rare exhibition, my neck is stretched as far as possible right now. I am all in on $RLFTF.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
